|
|
Previous Article | Table of Contents | Next Article 
An autocrine role for erythropoietin in mouse hematopoietic cell
differentiation [published erratum appears in Blood 1992 Jun
15;79(12):3397]
O Hermine, N Beru, N Pech and E Goldwasser
Department of Biochemistry and Molecular Biology, University of Chicago, IL
60637.
Erythropoietin (epo) is the primary regulator of the rate of red blood cell
formation in mammals. Because it is formed in the kidney and acts on the
bone marrow, its action is classically endocrine. We have shown by PCR that
marrow cells contain epo mRNA and that antisense oligodeoxynucleotides, to
both epo and its receptor, act on multipotent hematopoietic cells to cause
a decrease in mixed erythroid:nonerythroid colonies. The antisense
oligonucleotides also cause an increase in mixed nonerythroid colonies with
no effect on erythroid burst formation. Sense oligonucleotides have no
effect. The antisense suppression is not due to adherent cells, cycling
late differentiated cells or lymphocytes, and not reversed by exogenous
epo. We conclude that normal erythroid differentiation may have an early
phase that is dependent on an internal autocrine mechanism involving epo
and its receptor.
Volume 78,
Issue 9,
pp. 2253-2260,
11/01/1991
Copyright © 1991 by The American Society of Hematology

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. N. Re and J. L. Cook
The physiological basis of intracrine stem cell regulation
Am J Physiol Heart Circ Physiol,
August 1, 2008;
295(2):
H447 - H453.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Scortegagna, K. Ding, Q. Zhang, Y. Oktay, M. J. Bennett, M. Bennett, J. M. Shelton, J. A. Richardson, O. Moe, and J. A. Garcia
HIF-2{alpha} regulates murine hematopoietic development in an erythropoietin-dependent manner
Blood,
April 15, 2005;
105(8):
3133 - 3140.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Matsuzaki, T. Murakami, S. Uehara, R. Yokomizo, T. Noda, Y. Kimura, and K. Okamura
Erythropoietin concentrations are elevated in the peritoneal fluid of women with endometriosis
Hum. Reprod.,
May 1, 2001;
16(5):
945 - 948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tordjman, S. Delaire, J. Plouet, S. Ting, P. Gaulard, S. Fichelson, P.-H. Romeo, and V. Lemarchandel
Erythroblasts are a source of angiogenic factors
Blood,
April 1, 2001;
97(7):
1968 - 1974.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. L. Ebert and H. F. Bunn
Regulation of the Erythropoietin Gene
Blood,
September 15, 1999;
94(6):
1864 - 1877.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Fairchild Benyo and K. P. Conrad
Expression of the Erythropoietin Receptor by Trophoblast Cellsin the Human Placenta
Biol Reprod,
April 1, 1999;
60(4):
861 - 870.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Dame, H. Fahnenstich, P. Freitag, D. Hofmann, T. Abdul-Nour, P. Bartmann, and J. Fandrey
Erythropoietin mRNA Expression in Human Fetal and Neonatal Tissue
Blood,
November 1, 1998;
92(9):
3218 - 3225.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Stopka, J.H. Zivny, P. Stopkova, J.F. Prchal, and J.T. Prchal
Human Hematopoietic Progenitors Express Erythropoietin
Blood,
May 15, 1998;
91(10):
3766 - 3772.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. E.J. Rasko, E. O'Flaherty, and C. G. Begley
Mpl Ligand (MGDF) Alone and in Combination with Stem Cell Factor (SCF) Promotes Proliferation and Survival of Human Megakaryocyte, Erythroid and Granulocyte/Macrophage Progenitors
Stem Cells,
January 1, 1997;
15(1):
33 - 42.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
C. Stein and Y. Cheng
Antisense oligonucleotides as therapeutic agents--is the bullet really magical?
Science,
August 20, 1993;
261(5124):
1004 - 1012.
[Abstract]
[PDF]
|
 |
|
|
|